Australian Genomics: Outcomes of a 5-year national program to accelerate the integration of genomics in healthcare
- PMID: 36868206
- PMCID: PMC10027474
- DOI: 10.1016/j.ajhg.2023.01.018
Australian Genomics: Outcomes of a 5-year national program to accelerate the integration of genomics in healthcare
Abstract
Australian Genomics is a national collaborative partnership of more than 100 organizations piloting a whole-of-system approach to integrating genomics into healthcare, based on federation principles. In the first five years of operation, Australian Genomics has evaluated the outcomes of genomic testing in more than 5,200 individuals across 19 rare disease and cancer flagship studies. Comprehensive analyses of the health economic, policy, ethical, legal, implementation and workforce implications of incorporating genomics in the Australian context have informed evidence-based change in policy and practice, resulting in national government funding and equity of access for a range of genomic tests. Simultaneously, Australian Genomics has built national skills, infrastructure, policy, and data resources to enable effective data sharing to drive discovery research and support improvements in clinical genomic delivery.
Copyright © 2023 American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests R.L.W. is the Chair of the Medical Services Advisory Committee; the views in this paper are not representing those of the Commonwealth of Australia. I.E.S. has served on scientific advisory boards for BioMarin, Chiesi, Eisai, Encoded Therapeutics, GlaxoSmithKline, Knopp Biosciences, Nutricia, Rogcon, Takeda Pharmaceuticals, UCB, and Xenon Pharmaceuticals; has received speaker honoraria from GlaxoSmithKline, UCB, BioMarin, Biocodex, Chiesi, Liva Nova, Nutricia, Zuellig Pharma, and Eisai; has received funding for travel from UCB, Biocodex, GlaxoSmithKline, Biomarin, and Eisai; has served as an investigator for Anavex Life Sciences, Cerecin Inc, Cerevel Therapeutics, Eisai, Encoded Therapeutics, EpiMinder Inc, Epygenyx, ES-Therapeutics, GW Pharma, Marinus, Neurocrine BioSciences, Ovid Therapeutics, Takeda Pharmaceuticals, UCB, Ultragenyx, Xenon Pharmaceuticals, Zogenix, and Zynerba; and has consulted for Care Beyond Diagnosis, Epilepsy Consortium, Atheneum Partners, Ovid Therapeutics, UCB, Zynerba Pharmaceuticals, BioMarin, Encoded Therapeutics, and Biohaven Pharmaceuticals; and is a Non-Executive Director of Bellberry Ltd and a Director of the Australian Academy of Health and Medical Sciences and the Australian Council of Learned Academies Limited. She may accrue future revenue on pending patent WO61/010,176 (filed: 2008): Therapeutic Compound; has a patent for SCN1A testing held by Bionomics Inc and licensed to various diagnostic companies; and has a patent molecular diagnostic/theranostic target for benign familial infantile epilepsy (BFIE) (PRRT2) 2,011,904,493 & 2,012,900,190 and PCT/AU2012/001,321 (TECH ID:2012-009).
Figures


Similar articles
-
Australian Genomics: A Federated Model for Integrating Genomics into Healthcare.Am J Hum Genet. 2019 Jul 3;105(1):7-14. doi: 10.1016/j.ajhg.2019.06.003. Am J Hum Genet. 2019. PMID: 31271757 Free PMC article.
-
Improved Diagnosis and Care for Rare Diseases through Implementation of Precision Public Health Framework.Adv Exp Med Biol. 2017;1031:55-94. doi: 10.1007/978-3-319-67144-4_4. Adv Exp Med Biol. 2017. PMID: 29214566 Review.
-
The Experience and Effectiveness of Nurse Practitioners in Orthopaedic Settings: A Comprehensive Systematic Review.JBI Libr Syst Rev. 2012;10(42 Suppl):1-22. doi: 10.11124/jbisrir-2012-249. JBI Libr Syst Rev. 2012. PMID: 27820153
-
Healthcare System Priorities for Successful Integration of Genomics: An Australian Focus.Front Public Health. 2019 Mar 11;7:41. doi: 10.3389/fpubh.2019.00041. eCollection 2019. Front Public Health. 2019. PMID: 30915324 Free PMC article. Review.
-
A Maturity Matrix for Nurse Leaders to Facilitate and Benchmark Progress in Genomic Healthcare Policy, Infrastructure, Education, and Delivery.J Nurs Scholarsh. 2020 Sep;52(5):583-592. doi: 10.1111/jnu.12586. Epub 2020 Jun 27. J Nurs Scholarsh. 2020. PMID: 32592453 Free PMC article.
Cited by
-
Uptake of funded genomic testing for syndromic and non-syndromic intellectual disability in Australia.Eur J Hum Genet. 2023 Sep;31(9):977-979. doi: 10.1038/s41431-023-01417-6. Epub 2023 Jul 3. Eur J Hum Genet. 2023. PMID: 37400487 Free PMC article. No abstract available.
-
'Integrating Ethics and Equity with Economics and Effectiveness for newborn screening in the genomic age: A qualitative study protocol of stakeholder perspectives.PLoS One. 2024 Mar 25;19(3):e0299336. doi: 10.1371/journal.pone.0299336. eCollection 2024. PLoS One. 2024. PMID: 38527031 Free PMC article.
-
Adopting Public Health Genomics when the House Is on Fire: How Will We Navigate to 2030?Public Health Genomics. 2025;28(1):53-65. doi: 10.1159/000543161. Epub 2025 Jan 2. Public Health Genomics. 2025. PMID: 39746335 Free PMC article. No abstract available.
-
Review: Utility of mass spectrometry in rare disease research and diagnosis.NPJ Genom Med. 2025 Mar 31;10(1):29. doi: 10.1038/s41525-025-00487-3. NPJ Genom Med. 2025. PMID: 40164634 Free PMC article. Review.
-
The Health Economics of Genomic Technologies: A Growing Evidence Base on Value.Appl Health Econ Health Policy. 2025 May;23(3):331-335. doi: 10.1007/s40258-025-00970-z. Epub 2025 Apr 28. Appl Health Econ Health Policy. 2025. PMID: 40293671 Free PMC article. No abstract available.
References
-
- Turnbull C., Scott R.H., Thomas E., Jones L., Murugaesu N., Pretty F.B., Halai D., Baple E., Craig C., Hamblin A., et al. The 100 000 Genomes Project: bringing whole genome sequencing to the NHS. BMJ. 2018;361:k1687. - PubMed
-
- Fatumo S., Yakubu A., Oyedele O., Popoola J., Attipoe D.A., Eze-Echesi G., Modibbo F.Z., Ado-Wanka N., et al. 54gene Team. NCD-GHS Consortium Promoting the genomic revolution in Africa through the Nigerian 100K Genome Project. Nat. Genet. 2022;54:531–536. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources